News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline 8/27/2014
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014
BioGenerator Funds Woman-led EDIS Solutions 8/25/2014
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014
Easton Pharmaceuticals (OP: EAPH) Announces Financing Update; Provides Additional Due Diligence Documents To Canadian Based Brokerage Firm Towards Financing 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Landauer (LDR) Declares Regular Cash Dividend 8/25/2014
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In September 8/21/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Marina Biotech, Inc. (MRNA) Regains Compliance With Exchange Act Reporting Obligations 8/21/2014
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/20/2014
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014
Adamis Pharmaceuticals (ADMP) Announces Private Placement 8/20/2014
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces Upcoming 2014 Investor Conference Presentations 8/19/2014
Mallinckrodt Now A Component Of The S&P 500 Index 8/19/2014
Invitation To Extraordinary General Meeting Of Shareholders Of Recipharm AB 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/19/2014
Northwest Biotherapeutics (NWBO) Completes The Closing Of Its $17.5 Million Convertible Note Offering 8/19/2014
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
H&Q Life Sciences Investors Declares Stock Distribution 8/18/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
TNI BioTech Provides 2nd Notice of Annual Meeting September 4, 2014 8/18/2014
Dyadic International, Inc. Files Form 10 Registration Statement 8/18/2014
Insmed Incorporated (INSM) Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 8/18/2014
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014
NeoGenomics, Inc. (NGNM.OB) Announces Public Offering Of Common Stock 8/15/2014
TNI BioTech Announces An Extension To The Record Date Of Its Wholly Owned Subsidiary, Cytocom Inc., And Dividend Now Set For September 30, 2014 8/15/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Resverlogix Corporation (RVX.TO) Shareholders Approve Additional $30 Million From Citibank Loan 8/14/2014
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014
VistaGen Therapeutics, Inc. Announces Reverse Stock Split 8/14/2014
Northwest Biotherapeutics (NWBO) Announces Pricing Of $17.5 Million Offering Of Convertible Notes 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Novozymes, Inc. (NZYMb.CO) Increases 2014 Profit Outlook 8/14/2014
Celladon Corporation Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 8/13/2014
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014
Insmed Incorporated (INSM) Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Ligand Pharmaceuticals Inc. (LGND) Prices Offering Of $225 Million Of Convertible Senior Notes 8/13/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Prices $300 Million Convertible Senior Notes Offering 8/12/2014
Apricus Biosciences (APRI) Enters Into Common Stock Purchase Agreement With Aspire Capital 8/12/2014
Ligand Pharmaceuticals Inc. (LGND) Announces Proposed Offering Of $225 Million Of Convertible Senior Notes And Announces $200 Million Share Repurchase Program 8/12/2014
Insmed Incorporated (INSM) Announces Proposed Public Offering Of Common Stock 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
Cannabis Science Inc. Increases Equity Position To 50.1% In Michigan Green Technologies LLC, Positioning Company As Leader In Evolving Michigan Medical Cannabis And Hemp Industries 8/12/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars 8/12/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Intention To Offer $250 Million Of Convertible Notes 8/11/2014
Cellular Biomedicine Group (CBMG) To Ring The NASDAQ Stock Market Closing Bell 8/11/2014
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market 8/11/2014
PDL BioPharma, Inc. (PDLI) Announces Delay In Filing Quarterly Report On Form 10-Q 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Declares Dividend 8/11/2014
Galapagos NV (GLPG.BR) Cash Position Of €232 M Provides Solid Basis For R&D Pipeline Investment 8/8/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014
Celladon Corporation Announces Commencement Of Public Offering Of Common Stock 8/7/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014
CVS Caremark Corporation (CVS) Announces Cash Tender Offers For Its 6.250% Senior Notes Due 2027, 6.125% Senior Notes Due 2039, 5.750% Senior Notes Due 2041 And 5.750% Senior Notes Due 2017 8/7/2014
Aoxing Pharmaceutical Company Inc. (AXN) Receives Notice Of Extension From NYSE MKT LLC 8/7/2014
AmerisourceBergen Corporation (ABC) Declares Quarterly Dividend 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Zoetis (ZTS) Will Hold Its Inaugural Investor Day On November 18 8/5/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 8/4/2014
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014
Applied Genetic Technologies Corporation Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014
InVivo Therapeutics Corporation (NVIV) Announces Posting Of Management Presentation Recording From Annual Shareholders Meeting 8/1/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi 7/31/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results 7/31/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014
Incyte Corporation (INCY) Reports 2014 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 7/31/2014
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
All Proposals Approved At Teva Pharmaceutical Industries Limited (TEVA)'s Annual Meeting Of Shareholders 7/31/2014
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals 7/30/2014
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014 7/30/2014
Gevo, Inc. Announces Proposed Public Offering Of Common Stock And Warrants 7/30/2014
ContraFect Corporation (CFRXU) To Ring The NASDAQ Stock Market Opening Bell 7/30/2014
Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million 7/30/2014
Innophos Holdings, Inc. Declares Dividend Of $0.48 Per Share; Increases Rate By 20% 7/30/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Offering Of Common Stock 7/30/2014
Tauriga Sciences Inc. (TAUG) Approved To Continue Trading On OTCQB Marketplace 7/30/2014
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) (Publ) 7/30/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
La Jolla Pharmaceutical Company (LJPC) Closes Offering Of Common Stock 7/29/2014
SanguiBioTech GmbH Yields Revenues Of Around USD42,000 In Q4 2014 According To Preliminary Figures 7/29/2014
Axxess Pharma, Inc. Announces Audited Financials And S-1 Registration Statement Now Filed With SEC For Up-Listing To Over The Counter Bulletin Board (OTC: BB) Stock Exchange 7/29/2014
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card 7/28/2014
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014
Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders 7/25/2014
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs 7/24/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
Spherix (SPEX) Schedules Shareholder Update Call 7/24/2014
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting 7/24/2014
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend 7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
Merge Healthcare (MRGE) Sets Second Quarter 2014 Earnings Call 7/23/2014
BioAmber Inc. Announces Exercise In Full Of Underwriters' Option In Connection With Previously Priced Follow-On Offering 7/23/2014
La Jolla Pharmaceutical Company (LJPC) Announces Proposed Underwritten Offering Of Common Stock 7/23/2014
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS 7/22/2014
Johnson & Johnson (JNJ) Announces $5 Billion Share Repurchase Program 7/21/2014
SAGE Therapeutics Announces Full Exercise Of Over-Allotment Option 7/21/2014
Shareholders Support Management Proposals At SYGNIS’ AGM With Overwhelming Majority 7/21/2014
Sirona Biochem - CEO Letter To Shareholders 7/21/2014
IntelGenx Corp. To Host Management Call 7/21/2014
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
Centene Corporation Completes Transaction With Spanish Health Management Group 7/18/2014
Valeant Pharmaceuticals International (VRX) Files Investor Presentation 7/18/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Announces 2014 Second Quarter Results And Increases 2014 EPS Guidance 7/18/2014
SAGE Therapeutics Announces Pricing Of Initial Public Offering 7/18/2014
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014
Axxess Pharma, Inc. Announces Financial Audits And Form S-1 To Be Filed With SEC Within One Week For Fully Reporting Status 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014
Celator Pharmaceuticals, Inc. Provides Update On CPX-351 And Technology Platform At Analyst Day 7/17/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Esperion Therapeutics, Inc. (ESPR) To Host Inaugural Analyst And Investor Day 7/17/2014
Skystar Bio-Pharmaceutical (CGPN) Announces $5 Million Registered Direct Offering 7/17/2014
West Pharmaceutical Services Announces 10% Increase In Quarterly Dividend 7/17/2014
Cellular Biomedicine Group (CBMG) Raises $10 Million In Private Placement 7/16/2014
DIA Webinar With Veeva Systems, Inc. To Provide Insight On Improving Transparency And Collaboration With Regional Affiliates 7/16/2014
BTG plc (BTG.L): Interim Management Statement And Annual General Meeting 7/16/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Dipexium Pharmaceuticals (DPRX) To Ring The NASDAQ Stock Market Closing Bell 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
InSite Vision (ISV) To Webcast Annual Meeting Of Stockholders On July 16, 2014 7/16/2014
RestorGenex Announces Closing Of Its Private Placement Of Common Stock 7/15/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
StemCells Inc. (STEM) Announces Proposed $20 Million Offering 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Celsion Corporation (CLN) To Ring The NASDAQ Stock Market Closing Bell 7/15/2014
TNI BioTech Establishes New Record Date For Spin-Off Stock Dividend Of Cytocom, Inc. Shares 7/15/2014
Maxygen, Inc. (MAXY) Announces Revised Record Date For Final Liquidating Distribution 7/14/2014
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014
Helix Biopharma (CC:HBP) Announces Completion Of Private Placement 7/14/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Nuvilex (NVLX) Provides Shareholder Update On Milestone Accomplishments 7/14/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell 7/14/2014
Sinovac Biotech Ltd. (SVA) Schedules 2014 Annual Meeting Of Shareholders 7/14/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Provide Update On Transaction 7/14/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014
PuriCore: Trading Update and Strategic Review 7/11/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell July 15th 7/11/2014



//-->